STAT September 13, 2021
Helen Branswell

In early January 2020, most of the world hadn’t yet awakened to the fact that life was soon to change profoundly. But Barney Graham saw a possible need coming, and set out to fill it.

Graham was deputy director of the National Institutes of Health’s Vaccine Research Center and chief of the viral pathogenesis laboratory. Mere days after Chinese scientists posted to an international database the genetic sequence of a new, as yet unnamed coronavirus that was causing a fast-expanding outbreak in Wuhan, Graham and his colleague Kizzmekia Corbett had designed the structure for a vaccine that later became the prototype for Moderna’s Covid-19 shot and laid the foundation for Covid vaccines made by Johnson & Johnson, Novavax, and others.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Share This Article